Investor RelationsBG Medicine is a privately held company founded in 2000 by Flagship Ventures. Since its inception it has received over $90 Million in equity funding from its institutional investors Flagship Ventures, Gilde Investment Management, Legg Mason Capital Management, GE Asset Management, and SMALLCAP World Fund—and from strategic investors, including Humana, Royal Philips, and Waters Corporation.
|